Effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats

Molecular Brain Research

Volumn 100, Issue 1-2, 2002, Pages 1-12

  Gotoh, Leo ^a   Kawanami, Noriko ^a   Nakahara, Tatsuo ^a   Hondo, Hisao ^b   Motomura, Keisuke ^b   Ohta, Eiko ^a   Kanchiku, Izumi ^a   Kuroki, Toshihide ^c   Hirano, Makoto ^b   Uchimura, Hideyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Adenosine; Immediate early genes; Locomotion; N6 Cyclopentyladenosine; Phencyclidine; Stereotypy

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE RECEPTOR; MESSENGER RNA; NEUROLEPTIC AGENT; PHENCYCLIDINE; PROTEIN; PROTEIN ARC; PROTEIN C FOS; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG EFFECT; GENE EXPRESSION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TASK PERFORMANCE;

ADENOSINE; ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; GYRUS CINGULI; HALLUCINOGENS; HEAD MOVEMENTS; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NUCLEUS ACCUMBENS; PHENCYCLIDINE; PREFRONTAL CORTEX; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; PSYCHOTIC DISORDERS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RNA, MESSENGER;

EID: 18344374858     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00136-5     Document Type: Article

References (60)

1. Characterization of MK-801-induced behavior as a putative rat model of psychosis
2. A complex program of striatal gene expression induced by dopaminergic stimulation
3. Homovanillic acid in rat caudate and prefrontal cortex following phencyclidine and amphetamine
4. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients
5. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
6. Adenosine: Does it have a neuroprotective role after all?
7. The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and pathogenesis of schizophrenia
8. The nucleus accumbens core and shell: Accumbal compartments and their functional attributes
9. The effects of antipsychotic drugs on fos protein expression in the prefrontal cortex: Cellular localization
10. Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action
11. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: Contrasting pattern to striatal response
12. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
13. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia
14. 1 receptors
15. Activation of arc, a putative 'Effector' immediate early gene, by cocaine in rat brain
16. Evidence for adenosine/dopamine receptor interactions: Indications for heteromerization
17. Purinoceptors in the nervous system
18. 1 receptor interactions in the basal ganglia
19. Phencyclidine produces changes in NMDA and kinate receptor binding in rat hippocampus over a 48-hour time course
20. 1 receptors form functionally interacting heteromeric complexes
21. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice
22. 2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain
23. Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis
24. Effect of phencyclidine on dopamine release in the rat prefrontal cortex: An in vivo microdialysis study
25. 2C/2B receptor antagonists: Neurochemical and behavioural studies
26. Effect of phencyclidine in chronic schizophrenics
27. Recent advances in the phencyclidine model of schizophrenia
28. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
29. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: Behavioral and neurochemical evidence
30. 2 receptor explain the action of atypical antipsychotics?: A new hypothesis
31. Frontal lobe dysfunctions in schizophrenia II: Impairments of psychological and brain functions
32. Purinergic systems
33. Somatodendritic expression of an immediate early gene is regulated by synaptic activity
34. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites
35. The synthesis of phencyclidine and other 1-arylcyclohexylamines
36. 1 receptors, using in vivo and in vitro techniques
37. 2A receptors
38. Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens
39. 2A sites for PCP-induced locomotion in the rat
40. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
41. 2A receptors: An overview
42. Development of tolerance and supersensitivity to phencyclidine in rat after repeated administration of phencyclidine
43. 2 receptors by sulfhydryl-modifying reagents
44. Regional distribution of DNA and RNA in rat brain: A sensitive determination using high-performance liquid chromatography with electrochemical detection
45. Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain
46. Effects of phencyclidine on immediate early gene expression in the brain
47. Glutamate receptor dysfunction and schizophrenia
48. 2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine
49. 2A receptors in the induction of c-fos expression by clozapine and haloperidol
50. 2A agonists: A potential new type of atypical antipsychotic
51. Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain
52. An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons
53. 6-cyclopentyladenosine blocks the disruptive effect of phencyclidine on prepulse inhibition of the acoustic startle response in the rat
54. Phencyclidine
55. Adenosine as a neuromodulator
56. Phencyclidine-induced expression of c-Fos-like immunoreactivity in mouse brain regions
57. 1 receptors in phencyclidine-induced behavioral stimulation in rats
58. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine-metabolism in the rat
59. Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus
60. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice